167 related articles for article (PubMed ID: 28492398)
21. Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin.
Parisi SG; Loregian A; Andreis S; Nannetti G; Cavinato S; Basso M; Scaggiante R; Dal Bello F; Messa L; Cattelan AM; Palù G
Int J Infect Dis; 2016 Aug; 49():151-3. PubMed ID: 27378577
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients.
Navarro J; Laguno M; Vilchez HH; Guardiola JM; Carrion JA; Force L; Cairó M; Cifuentes C; Vilaró J; Cucurull J; Marco A; Roget M; Erice E; Crespo M;
J Antimicrob Chemother; 2017 Oct; 72(10):2850-2856. PubMed ID: 29091196
[TBL] [Abstract][Full Text] [Related]
23. High rates of hepatitis C virus (HCV) cure using direct-acting antivirals in HIV/HCV-coinfected patients: a real-world perspective.
Hawkins C; Grant J; Ammerman LR; Palella F; Mclaughlin M; Green R; Mcgregor D; Stosor V
J Antimicrob Chemother; 2016 Sep; 71(9):2642-5. PubMed ID: 27330060
[TBL] [Abstract][Full Text] [Related]
24. Successful Treatment of Chronic Hepatitis E After an Orthotopic Liver Transplant With Ribavirin Monotherapy.
Klein F; Neuhaus R; Hofmann J; Rudolph B; Neuhaus P; Bahra M
Exp Clin Transplant; 2015 Jun; 13(3):283-6. PubMed ID: 24779678
[TBL] [Abstract][Full Text] [Related]
25. The challenge of chronic hepatitis E in liver transplant recipients: Failure of sofosbuvir plus ribavirin therapy.
Sastre L; García-López M; Pérez-Del-Pulgar S; Lens S; Costa J; Navasa M; Forns X
Gastroenterol Hepatol; 2020 Mar; 43(3):136-137. PubMed ID: 31902599
[No Abstract] [Full Text] [Related]
26. HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.
Bihl F; Martinetti G; Wandeler G; Weber R; Ledergeber B; Calmy A; Battegay M; Cavassini M; Vernazza P; Caminada AP; Rickenbach M; Bernasconi E;
BMC Gastroenterol; 2015 Jul; 15():79. PubMed ID: 26152237
[TBL] [Abstract][Full Text] [Related]
27. Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
Grant JL; Hawkins C; Brooks H; Palella FJ; Koppe SW; Abecassis MM; Stosor V
AIDS; 2016 Jan; 30(1):93-8. PubMed ID: 26731756
[TBL] [Abstract][Full Text] [Related]
28. Tenofovir disoproxil treatment for a HIV-hepatitis B virus coinfected patient undergoing peritoneal dialysis: which dose do we need?
Aleman J; van den Berk GE; Franssen EJ; de Fijter CW
AIDS; 2015 Jul; 29(12):1579-80. PubMed ID: 26244398
[No Abstract] [Full Text] [Related]
29. Daclatasvir and Sofosbuvir Versus Sofosbuvir and Ribavirin in Patients with Chronic Hepatitis C Coinfected with HIV: A Matching-adjusted Indirect Comparison.
Swallow E; Song J; Yuan Y; Kalsekar A; Kelley C; Peeples M; Mu F; Ackerman P; Signorovitch J
Clin Ther; 2016 Feb; 38(2):404-12. PubMed ID: 26839044
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis E virus as a causative agent of unexplained liver enzyme elevations in HIV-infected patients.
van Welzen BJ; Verduyn Lunel FM; Meindertsma F; Hoepelman AI; Arends JE
J Acquir Immune Defic Syndr; 2012 Jun; 60(2):e65-7. PubMed ID: 22622079
[No Abstract] [Full Text] [Related]
31. Ribavirin long-term treatment for chronic hepatitis E virus infection in a liver transplant recipient.
Casper M; Reichert MC; Rissland J; Grünhage F; Lammert F
Dig Liver Dis; 2020 Aug; 52(8):926-927. PubMed ID: 32553699
[No Abstract] [Full Text] [Related]
32. Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders.
Uemura H; Tsukada K; Mizushima D; Aoki T; Watanabe K; Kinai E; Teruya K; Gatanaga H; Kikuchi Y; Sugiyama M; Mizokami M; Oka S
PLoS One; 2017; 12(10):e0186255. PubMed ID: 29045448
[TBL] [Abstract][Full Text] [Related]
33. Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with ribavirin.
Ambrosioni J; Mamin A; Hadengue A; Bernimoulin M; Samii K; Landelle C; Negro F; Kaiser L
Clin Microbiol Infect; 2014 Oct; 20(10):O718-20. PubMed ID: 24476456
[TBL] [Abstract][Full Text] [Related]
34. Predictors of treatment efficacy and ALT non-normalization with sofosbuvir/ribavirin therapy for patients with hepatitis C virus genotype 2.
Watanabe T; Tokumoto Y; Joko K; Michitaka K; Horiike N; Tanaka Y; Tada F; Kisaka Y; Nakanishi S; Nonaka T; Yamauchi K; Hirooka M; Abe M; Hiasa Y
J Med Virol; 2017 Sep; 89(9):1567-1573. PubMed ID: 28165154
[TBL] [Abstract][Full Text] [Related]
35. A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.
Murata M; Furusyo N; Ogawa E; Mitsumoto F; Hiramine S; Ikezaki H; Takayama K; Shimizu M; Toyoda K; Kainuma M; Hayashi J
J Infect Chemother; 2014 May; 20(5):320-4. PubMed ID: 24477330
[TBL] [Abstract][Full Text] [Related]
36. Antihepatitis C virus treatments for HIV-hepatitis C virus coinfected cirrhotic patients: a need to look beyond the sustained viral response.
Zucman D; Sené T; Hillaire S; Kahn JE; Farfour E; Peytavin G
AIDS; 2015 Sep; 29(14):1903-4. PubMed ID: 26372397
[No Abstract] [Full Text] [Related]
37. Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes.
Younossi ZM; Stepanova M; Sulkowski M; Naggie S; Puoti M; Orkin C; Hunt SL
J Infect Dis; 2015 Aug; 212(3):367-77. PubMed ID: 25583164
[TBL] [Abstract][Full Text] [Related]
38. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.
Fabbri G; Mastrorosa I; Vergori A; Mazzotta V; Pinnetti C; Grisetti S; Zaccarelli M; Ammassari A; Antinori A
BMC Infect Dis; 2017 Mar; 17(1):182. PubMed ID: 28249574
[TBL] [Abstract][Full Text] [Related]
39. Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting.
Galante A; Pischke S; Polywka S; Luetgehethmann M; Suneetha PV; Gisa A; Hiller J; Dienes HP; Nashan B; Lohse AW; Sterneck M
Transpl Infect Dis; 2015 Aug; 17(4):617-22. PubMed ID: 26094550
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis.
Merli M; Galli L; Marinaro L; Ariaudo A; Messina E; Uberti-Foppa C; Castagna A; D'Avolio A; Lazzarin A; Bonora S; Hasson H
J Antimicrob Chemother; 2017 Mar; 72(3):812-815. PubMed ID: 27999010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]